Home/Filings/4/0001209191-21-006069
4//SEC Filing

Ziolkowski Jennifer Lynn 4

Accession 0001209191-21-006069

CIK 0001707502other

Filed

Jan 28, 7:00 PM ET

Accepted

Jan 29, 4:00 PM ET

Size

9.1 KB

Accession

0001209191-21-006069

Insider Transaction Report

Form 4
Period: 2021-01-27
Transactions
  • Sale

    Common Stock

    2021-01-28$6.14/sh3,473$21,327335,636 total
  • Exercise/Conversion

    Restricted Stock Units

    2021-01-2711,5000 total
    Common Stock (11,500 underlying)
  • Exercise/Conversion

    Common Stock

    2021-01-27+11,500339,109 total
Footnotes (3)
  • [F1]Restricted Stock units convert into common stock on a one-for-one basis.
  • [F2]This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units.
  • [F3]On January 27, 2020, the reporting person was granted 23,000 restricted stock units, vesting in two equal installments. Fifty percent vested six months after the grant date with the remaining fifty percent vesting on the first anniversary of the grant date.

Issuer

Solid Biosciences Inc.

CIK 0001707502

Entity typeother

Related Parties

1
  • filerCIK 0001727410

Filing Metadata

Form type
4
Filed
Jan 28, 7:00 PM ET
Accepted
Jan 29, 4:00 PM ET
Size
9.1 KB